SH

Shraddha Hardik Patel

Active Director Director DIN 10088459
DIN 10088459 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Shraddha Hardik Patel

Data last updated:

Shraddha Hardik Patel is a Director at Pinksky Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Pinksky Pharmaceuticals Private Limited reported revenue of ₹2.7 Lakh (FY 2025).

DIN 10088459
Primary Designation Director
Industry Pharma
First Appointment 25 Mar 2023
Oldest Company Age 3 yrs
Largest company Pinksky Pharmaceuticals Private Limited · ₹2.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Mar 20232023₹2.7 Lakh (FY 2025)Active

Board colleagues of Shraddha Hardik Patel

Directorship timeline

Open interactive timeline →
Pinksky Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shraddha Hardik Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shraddha Hardik Patel

Shraddha Hardik Patel currently holds 1 directorship: Pinksky Pharmaceuticals Private Limited (Director, since 25 Mar 2023, revenue ₹2.7 Lakh (FY 2025)).

Shraddha Hardik Patel was first appointed on 25 Mar 2023 as Director at Pinksky Pharmaceuticals Private Limited.

The current boards of Shraddha Hardik Patel's companies include Hardik Girishkumar Patel (Pinksky Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available